JP Morgan Chase’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-101,400
Closed -$5.47M 7711
2023
Q2
$5.47M Buy
101,400
+55,400
+120% +$2.98M ﹤0.01% 2790
2023
Q1
$2.5M Sell
46,000
-35,100
-43% -$1.71M ﹤0.01% 3380
2022
Q4
$3.93M Buy
81,100
+32,300
+66% +$1.42M ﹤0.01% 3025
2022
Q3
$1.85M Buy
+48,800
New +$2.17M ﹤0.01% 3537
2022
Q1
Sell
-49,500
Closed -$2.48M 6977
2021
Q4
$2.48M Sell
49,500
-82,200
-62% -$4.07M ﹤0.01% 3688
2021
Q3
$6.35M Hold
131,700
﹤0.01% 2830
2021
Q2
$6.93M Buy
+131,700
New +$6.87M ﹤0.01% 2754
2020
Q1
Sell
-11,900
Closed -$597K 5688
2019
Q4
$597K Buy
+11,900
New +$557K ﹤0.01% 4152
2019
Q3
Sell
-152,200
Closed -$6.56M 5938
2019
Q2
$6.56M Buy
152,200
+60,000
+65% +$2.55M ﹤0.01% 2429
2019
Q1
$4.08M Buy
+92,200
New +$3.95M ﹤0.01% 2751
2017
Q4
Sell
-40,000
Closed -$1.98M 5567
2017
Q3
$1.98M Buy
+40,000
New +$1.94M ﹤0.01% 3163
2016
Q3
Sell
-22,400
Closed -$937K 4779
2016
Q2
$937K Buy
+22,400
New +$918K ﹤0.01% 3204

Other funds holding SNY

JP Morgan Chase's SNY Position: Q1 2026 in Review

JP Morgan Chase increased its Sanofi (SNY) stake by 86% in Q1 2026, buying an estimated $121M and bringing the position to 5,600,731 shares worth $262M. The position accounts for 0.02% of the portfolio, ranked #592.

JP Morgan Chase first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • JP Morgan Chase held 5,600,731 shares of Sanofi worth $262M as of Q1 2026.
  • JP Morgan Chase bought 2,589,773 Sanofi shares in Q1 2026, an estimated $121M.
  • Sanofi made up 0.02% of JP Morgan Chase's portfolio in Q1 2026, its #592 holding.
  • JP Morgan Chase first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • 739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.